NCT06272383View on ClinicalTrials.gov

Croup Dosing Study

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

January 28, 2025

Study Completion Date

February 20, 2025

Conditions
Croup
Interventions
DRUG

0.15 mg/kg dexamethasone

25% less than the standard practice of dexamethasone at 0.6mg/kg

Trial Locations (1)

Unknown

Children's Hospital Winnipeg, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT06272383 - Croup Dosing Study | Biotech Hunter | Biotech Hunter